Chairman and CEO
Jeffrey S. Aronin is a business leader, life science investor, entrepreneur and philanthropist. He is the chairman and CEO of Marathon Pharmaceuticals.
Marathon Pharmaceuticals is a prescription pharmaceutical company that develops, manufactures and commercializes high-need pharmaceutical products for patients with rare diseases.
Prior to Marathon, Mr. Aronin founded Ovation Pharmaceuticals, Inc. Under Mr. Aronin’s leadership, Ovation became one of the world’s premier drug companies developing drugs for rare diseases. Ovation was sold in 2009 to Lundbeck for $900 million. After the acquisition, Mr. Aronin served as Lundbeck’s president and chief executive officer.
Mr. Aronin serves on several business and civic boards including Discover Financial Services (NYSE), the Executive Committee of World Business Chicago (appointed by Mayor Emanuel), the Executive Committee of the Economic Club of Chicago, the Executive Committee of the Commercial Club of Chicago, Chicago Next, among others. He is also a Henry Crown Fellow at the Aspen Institute.
Mr. Aronin has been inducted into the Chicago Entrepreneur Hall of Fame. He was also honored with the Ernst and Young Entrepreneur of the Year Award. He is the founder of MATTER, a successful healthcare technology incubator center created to support entrepreneurs.